Hyper Corporation

Hyper Corporation Operating Cash Flow

The Operating Cash Flow of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is -8.29 B KRW. In the previous year, Operating Cash Flow was -4.54 B KRW — a change of 82.82% (lower).

Operating Cash Flow

-8.29 BKRW

YoY

82.82%

Last updated:

Operating Cash Flow of Hyper Corporation is 2025 -8.29 B KRW. Operating Cash Flow of Hyper Corporation was 2024 -4.54 B KRW. It decreases by 82.82% lower compared to the previous year.

The Hyper Corporation Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
-852.48 M KRW
Jan 1, 2019
-4.28 B KRW
Jan 1, 2020
-1.67 B KRW
Jan 1, 2021
-1.50 B KRW
Jan 1, 2022
-2.91 B KRW
Jan 1, 2023
-2.14 B KRW
Jan 1, 2024
-4.54 B KRW
Jan 1, 2025
-8.29 B KRW
The Hyper Corporation Operating Cash Flow history
YEAROperating Cash FlowYoY
-8.29 BKRW+82.82%
-4.54 BKRW+112.11%
-2.14 BKRW-26.62%
-2.91 BKRW+93.93%
-1.50 BKRW-10.24%
-1.67 BKRW-60.93%
-4.28 BKRW+402.59%
-852.48 MKRW-27.16%
-1.17 BKRW+1.60%
-1.15 BKRW+576.52%
-170.27 MKRW-24,355.77%
701,960.00KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Operating Cash Flow of Hyper Corporation is -8.29 B KRW in 2025.

Operating Cash Flow of Hyper Corporation changed from -4.54 B KRW to -8.29 B KRW, representing a 82.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Hyper Corporation

All Key Metrics — Hyper Corporation